Clinical Trials Logo

Filter by:
NCT ID: NCT04639076 Completed - Clinical trials for Overweight and Obesity

Study of a Personalized vs. Standard Approach to Weight Loss Recommendations

mPWR
Start date: October 21, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to develop and test the feasibility of a behavioral weight loss intervention that uses personalized recommendations for diet and physical activity behaviors in a behavioral weight loss program and to explore factors associated with treatment adherence and response. The 12-week intervention will utilize digital tools for self-monitoring and counseling by weight management professionals. Exploratory analyses will be conducted to determine if there are genetic, metabolomic, microbiome, or psychosocial factors associated with treatment response.

NCT ID: NCT04638998 Completed - Gulf War Syndrome Clinical Trials

Assessing Neuroinflammation in GWI Using MRS

Start date: December 1, 2020
Phase:
Study type: Observational

The primary aim of this study is to determine if Gulf War Illness (GWI) likely involves neuroinflammation. The investigators hypothesize that GWI involves neuroinflammation. By assessing the five neuroinflammatory outcomes across the brain, the investigators can determine if there are focal or global signs of one or more neuroinflammatory markers in the brains of individuals with GWI. This neuroimaging technique may allow investigators and others to detect cases of GWI neuroinflammation, which would improve treatment decisions as well as the development of new targeted therapies. It is an ideal diagnostic tool because it has low patient risk, is noninvasive, can be used repeatedly in longitudinal studies, provides whole-brain coverage, yields multiple independent markers of inflammation, and can be employed at most hospitals and research neuroimaging suites.

NCT ID: NCT04638881 Completed - Esophageal Spasm Clinical Trials

Magnesium for Peroral Endoscopic Myotomy

MgPOEM
Start date: December 28, 2020
Phase: Phase 2
Study type: Interventional

Postoperative pain after peroral endoscopic myotomy occurs due to involuntary esophageal smooth muscle spasms. Magnesium has antispasmodic properties as a smooth muscle relaxant. This study hypothesizes that among patients having peroral endoscopic myotomy, magnesium will decrease postoperative esophgeal pain as measured by the esophageal symptoms questionnaire, while decreasing perioperative opioid requirements.

NCT ID: NCT04638829 Completed - Clinical trials for Immune Thrombocytopenia

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Start date: March 15, 2021
Phase: Phase 4
Study type: Interventional

Evaluate the safety and tolerability of avatrombopag given for 90 days after stopping treatment with eltrombopag or romiplostim.

NCT ID: NCT04638803 Completed - Healthy Volunteers Clinical Trials

Microdose Pharmacokinetic Study of PRX-P4-003 In Healthy Volunteers

Start date: February 25, 2021
Phase: Early Phase 1
Study type: Interventional

The goal of the present study is to confirm in humans the in-vivo bioconversion of a Prodrug (PRX-P4-003) to (-)-fencamfamine (FCF) the active moiety when orally administered as a single microdose. A second component of the study will evaluate effect of food on pharmacokinetics of PRX-P4-003.

NCT ID: NCT04638673 Completed - Covid19 Clinical Trials

NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis

Start date: November 19, 2020
Phase: Phase 2
Study type: Interventional

The purpose of the research is to test out a new form of treatment that examines stimulation of a nerve in the participant's ear. This is called transcutaneous (through the skin) auricular (ear) vagus nerve stimulation (taVNS) which means that the participant will receive stimulation through the ear. The taVNS device looks like an ear bud used with a smart phone or computer. The study team is investigating whether or not taVNS can treat neurologic symptoms of COVID-19 which are termed NEUROCOVID. Some symptoms the participant may experience are new onset anxiety, depression, vertigo, loss of smell, headaches, fatigue, irritability, etc. This study is entirely online and all assessments will be completed virtually.

NCT ID: NCT04638660 Completed - Clinical trials for Dim Light Vision Disturbances

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances

Start date: December 30, 2020
Phase: Phase 3
Study type: Interventional

The objectives of this study are: - To evaluate the efficacy of Nyxol to improve mesopic low contrast visual acuity (mLCVA) in subjects with Dim Light Vision Disturbances (DLD) - To evaluate efficacy of Nyxol to improve visual performance - To evaluate the safety of Nyxol

NCT ID: NCT04638595 Completed - Pediatric ALL Clinical Trials

Pediatric Normative Movement Analysis Data Collection

Start date: November 16, 2020
Phase:
Study type: Observational

The objective of this project is to collect baseline data from a normative population of children that gender and age matches the population of patients expected to be treated by Mary Bridge Children's Therapy Services and seen in the Research and Movement Laboratory. This project seeks to recruit 25 male and 25 female typically developing children between the ages of 3 and 18 years of age. Non-invasive measurements of movement patterns will be collected during common activities of daily living over a single data collection session.

NCT ID: NCT04638127 Completed - Parenting Clinical Trials

PREEMIE PROGRESS: A Family Management Program for Parents of Preterm Infants

Start date: May 17, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to refine and pilot test a mobile health (mHealth), video-based family management program for parents of preterm infants hospitalized in the Neonatal Intensive Care Unit (NICU). By moving beyond the basic infant care tasks taught by parenting programs and instead comprehensively training parents to use evidence-based family management skills, we hypothesize that our intervention, called PREEMIE PROGRESS, will better equip parents to meet the chronic, complex healthcare needs of their preterm infant.

NCT ID: NCT04638010 Completed - Cancer Prevention Clinical Trials

Increasing Breast, Cervical, and Colorectal Cancer Screening and HPV Vaccination Among Underserved Texans

Start date: February 16, 2011
Phase: N/A
Study type: Interventional

This study involves a partnership between UTHealth School of Public Health and the Texas 2-1-1 service, which is a helpline connecting low-income and minority callers with a number of needed services. The purpose of this study is to evaluate the effectiveness of a prevention program in which a phone navigator intervention designed to connect 2-1-1 helpline callers to evidence-based screening and prevention services including mammography, Pap test screening, colorectal cancer screening, and HPV vaccination.